U.S. Medical Equipment Stock News

In May 2026, Vestis Corporation reported second-quarter sales of US$659.44 million, a slight decline from US$665.25 million a year earlier, while swinging from a US$27.83 million net loss to a US$2.6 million net profit and maintaining full-year 2026 revenue guidance for a 2% decline to flat performance. Despite broadly flat sales over the past six months, Vestis sharply reduced its net loss from US$27 million to US$3.8 million, highlighting how cost controls and better operating leverage are...

Qiagen (NYSE:QGEN) has put AI at the center of its story this month by launching the QIA Agent digital assistant for lab workflows and expanding its AI collaboration with NVIDIA in bioinformatics and drug discovery. See our latest analysis for Qiagen. Despite the AI announcements and a higher proposed dividend, Qiagen’s short term momentum is mixed, with the share price up over the past week but down about 26% year to date, and longer term total shareholder returns also negative. If Qiagen’s...

Earlier in 2026, Selective Insurance Group reported first-quarter results where operating income missed estimates as significantly higher catastrophe losses and weaker underwriting were only partly offset by stronger investment income; the company also repurchased US$30,000,000 of stock and declared a cash dividend payable on June 1, 2026. The earnings miss has sharpened investor focus on already slowing estimated sales growth, declining pre-tax profit margins, and earnings trends that have...

Wondering whether On Holding stock still offers value after all the recent noise, or if the current price already reflects the story you are buying into? The share price last closed at US$39.81, with the stock up 6.8% over the past week and 8.8% over the past month, yet still down 15.2% year to date and 31.9% over the past year. This combination presents both recovery hopes and questions about risk. Recent coverage has focused on how On Holding fits into premium sportswear trends and the...

FirstCash Holdings (FCFS) has drawn investor attention after its recent share performance, with the stock closing at US$227.59 and posting double digit total returns over the past year and the past 3 months. See our latest analysis for FirstCash Holdings. The recent move to US$227.59 comes on top of a 45.17% year to date share price return and an 80.26% 1 year total shareholder return, which points to strong, sustained momentum rather than a short term spike. If this kind of run has you...

Recent performance snapshot Recursion Pharmaceuticals (RXRX) has drawn investor attention after its share price closed at US$3.01, with the stock down about 19% over the past month and roughly 12% over the past 3 months. See our latest analysis for Recursion Pharmaceuticals. For context, RXRX’s 1-day share price return declined 3.22%, and the 30-day share price return is down 19.30%, while the 1-year total shareholder return has fallen 26.23%. This points to fading momentum after earlier...

Wondering if SPX Technologies at about US$207.80 is still offering value or if most of the opportunity is already priced in is a fair question for any investor looking at this stock today. The share price has returned 3.4% over the last 7 days, is down 5.8% over the last month, and shows gains of 2.2% year to date, 38.7% over 1 year and 171.4% over 3 years, which naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on SPX...

French's, a McCormick (NYSE:MKC) brand, has launched a national partnership with Illumination's "Minions & Monsters" movie. The tie up features limited edition French's packaging and a new French's Goomi's Green Mustard across U.S. retailers. The campaign adds in store and digital fan experiences that connect French's products with the film's characters and themes. For McCormick investors, this campaign lands at a time when NYSE:MKC trades around $47.8 and longer term returns have been...

Klaviyo (KVYO) is back on investors' radar after raising its full year revenue guidance following 28% Q1 revenue growth, while also disclosing that CFO Amanda Whalen plans to depart in August 2026. See our latest analysis for Klaviyo. The Q1 guidance upgrade and CFO transition come against a weak recent trading backdrop, with the share price down 27% over the past month and the 1 year total shareholder return also firmly negative. Recent insider selling and upcoming investor conference...

Air Products and Chemicals (NYSE:APD) has secured a long term contract with Samsung to supply specialty gases for a new semiconductor facility in South Korea. The agreement covers critical materials used in advanced chip production and ties APD to one of the largest electronics producers globally. The deal extends APD’s reach in the electronics and semiconductor segment, an area closely watched by investors tracking manufacturing supply chains. For APD, which already supplies industrial and...

Earlier in May, Progyny, Inc. presented at the Bank of America Global Healthcare Conference 2026 in Las Vegas, featuring CEO Peter Anevski and CFO Mark S. Livingston discussing its fertility and family-building benefits business. A recent research upgrade that highlighted Progyny’s consistent outperformance versus revenue and adjusted EBITDA estimates, alongside a more optimistic growth outlook, has sharpened investor focus on how its business is evolving. Next, we’ll examine how Progyny’s...

Wondering whether Ball stock at around US$56.51 is offering good value right now, or if the price already reflects the story you are buying into? Over the past week the share price is up 2.4%, although it is down 9.8% over the last 30 days, with returns of 5.9% year to date and 10.8% over the past year. Recent news coverage has focused on Ball as an established packaging business, with investors weighing up how the company fits into long term themes such as consumer demand and materials use...

TowneBank recently declared a second-quarter 2026 cash dividend of US$0.28 per share, following the completed US$250.00 million sale of its Resort Property Management business, a prior special dividend of US$0.70 per share, and approval of a US$25.00 million donation to the TowneBank Foundation. This combination of a higher recurring dividend, a one-time special payout, and a large charitable commitment highlights how TowneBank is reallocating capital while reinforcing its community-focused...

Western Midstream Partners (WES) is back in focus after first quarter 2026 results topped analyst expectations, helping the stock reach a fresh 52 week high and extending a four year streak of dividend increases. See our latest analysis for Western Midstream Partners. At a share price of $46.01, Western Midstream Partners has logged a 12.44% 1 month share price return and a 15.84% year to date share price return. The 1 year total shareholder return of 29.33% and 5 year total shareholder...

Investors may be wondering whether Hormel Foods at US$21.24 is starting to look interesting, or if the stock's weakness is signaling something important about its value. The share price has risen 7.6% over the past week, but is still down 0.9% over 30 days, 9.2% year to date and 24.3% over the last year. Over three years the decline is 37.8%, and over five years it is 48.5%. Recent coverage has focused on Hormel Foods as a long-established consumer staples stock in a period when investors...

If you are wondering whether Coca-Cola's current share price matches its underlying value, the recent trading history offers a useful starting point. The stock last closed at US$81.48, with returns of 0.8% over 7 days, 9.2% over 30 days, 17.9% year to date, 16.8% over 1 year, 47.9% over 3 years and 71.0% over 5 years. This helps frame how the market has been pricing the company in recent periods. Recent coverage has focused on how Coca-Cola is positioned within the global beverages sector...

Investors may be wondering whether Braze at around US$24.35 is starting to look like value, or if the stock still has more downside risk priced in. Over the past week the share price gained 16.7%, while the 30 day return is 1.2%. However, the stock is still down 25.2% year to date and down 29.9% over the past year, which may leave readers questioning how the recent rebound fits into the bigger picture. Recent news coverage has focused on Braze's position in customer engagement software and...

In the past week, Green Brick Partners reported first-quarter 2026 results with earnings per share and gross margin exceeding analyst expectations, even as revenue came in below forecasts. Analysts highlighted the stronger-than-expected order trends and sales absorption rates, underscoring demand resilience despite the softer top-line outcome. Now we will examine how stronger-than-expected sales absorption and orders may influence Green Brick Partners' existing investment narrative...

Curtiss-Wright recently entered into a new five-year syndicated revolving credit agreement, expanding its facility to US$1.00 billion with a US$500 million accordion feature maturing in May 2031, while also announcing a US$0.2600 quarterly dividend payable on July 6, 2026. By terminating its earlier, smaller facility and extending committed bank financing, the company has signaled an emphasis on funding potential acquisitions and internal growth while maintaining balance sheet...

Earlier this week, Boston Scientific reported that its pivotal FRACTURE IDE trial of the SEISMIQ 4CE coronary intravascular lithotripsy catheter met all primary safety and effectiveness endpoints in 420 patients with severely calcified coronary artery disease. The data showed high rates of freedom from major adverse cardiac events and consistent stent expansion in a particularly hard-to-treat patient group, supporting a regulatory submission for SEISMIQ 4CE. We’ll now examine how this...

Investors may be wondering if Westinghouse Air Brake Technologies at around US$256 per share is still good value after its strong run, or if most of the upside is already reflected in the price. The stock is up 18.6% year to date and 29.4% over the past year, although it has slipped 2.8% over the last week and 2.0% over the past month. These moves may have some investors reassessing the balance between opportunity and risk. Recent coverage has focused on how the company fits into rail and...

If you are wondering whether Regal Rexnord's current share price lines up with its underlying worth, the valuation story is where things start to get interesting. The stock recently closed at US$200.78, with returns of 1.8% over the past week, a decline of 4.9% over the past month, and gains of 37.4% year to date and 50.8% over the past year. Recent coverage around Regal Rexnord has focused on its role in the wider capital goods sector and how investors are reassessing companies linked to...

A. O. Smith (AOS) is back in focus after recent share price moves, with the stock down about 12% over the past month and about 26% over the past 3 months. See our latest analysis for A. O. Smith. Recent moves sit against a weaker backdrop, with the share price delivering a year to date share price return that is down 16.16% and a 1 year total shareholder return that is down 12.73%. This signals fading momentum despite the recent 7 day share price gain of 2.27% to $57.28. If A. O. Smith's...

Hope Bancorp (NasdaqGS:HOPE) announced an agreement to acquire SMBC Manubank’s commercial unit. The deal centers on commercial loans and deposits concentrated in the Los Angeles area. Management expects the transaction to expand the company’s loan and deposit base and to be accretive to earnings over time. For you as an investor, this move speaks directly to how Hope Bancorp is positioning its core business in commercial banking. The company is adding scale in a key market where business...